XWPharma Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
XWPharma General Information
Description
Developer of novel therapeutics intended to treat sleep, neuropsychiatric, and other underserved central nervous system disorders. The company specializes in drug discovery and vaccine development for neurological and neuropsychiatric disorders, enabling patients to overcome insomnia and other sleep disorders and lead healthy lives.
Contact Information
Website
www.xwpharma.comCorporate Office
- 3 Lagoon Drive
- Suite 160
- Redwood City, CA 94065
- United States
Corporate Office
- 3 Lagoon Drive
- Suite 160
- Redwood City, CA 94065
- United States
XWPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 06-Jun-2023 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC (Series C) | 17-Sep-2020 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC (Series B) | 20-Sep-2017 | Completed | Clinical Trials - Phase 2 | |||
| 2. Secondary Transaction - Private | 18-May-2017 | $5.5M | Completed | Clinical Trials - Phase 2 | ||
| 1. Early Stage VC (Series A) | 01-Sep-2014 | $5.5M | $5.5M | Completed | Clinical Trials - Phase 2 |
XWPharma Comparisons
Industry
Financing
Details
XWPharma Competitors (77)
One of XWPharma’s 77 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| NeuroNascent | Venture Capital-Backed | Clarksville, MD | ||||
| CuraSen | Venture Capital-Backed | San Carlos, CA | ||||
| Aquinnah | Venture Capital-Backed | Cambridge, MA | ||||
| T3D Therapeutics | Venture Capital-Backed | Durham, NC |
XWPharma Patents
XWPharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026096245-A1 | Crystalline 4-((l-valil)oxy)butanoic acid salts | Pending | 29-Oct-2024 | ||
| US-20260116843-A1 | Crystalline 4-((l-valyl)oxy)butanoic acid salts | Pending | 29-Oct-2024 | ||
| AU-2024316257-A1 | Excipient granulations | Pending | 31-Jul-2023 | ||
| EP-4753674-A2 | Excipient granulations | Pending | 31-Jul-2023 | ||
| US-20250041425-A1 | Excipient granulations | Pending | 31-Jul-2023 | A61K31/223 |
XWPharma Signals
XWPharma Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CDIB Capital Group | Asset Manager | Minority | ||
| Orient Hontai Capital | PE/Buyout | Minority | ||
| Panacea Capital (California) | Venture Capital | Minority | ||
| Trinity Innovation Fund | Venture Capital | Minority | ||
| Woori Venture Partners | Venture Capital | Minority |
XWPharma FAQs
-
When was XWPharma founded?
XWPharma was founded in 2014.
-
Where is XWPharma headquartered?
XWPharma is headquartered in Redwood City, CA.
-
What is the size of XWPharma?
XWPharma has 19 total employees.
-
What industry is XWPharma in?
XWPharma’s primary industry is Drug Discovery.
-
Is XWPharma a private or public company?
XWPharma is a Private company.
-
What is XWPharma’s current revenue?
The current revenue for XWPharma is .
-
How much funding has XWPharma raised over time?
XWPharma has raised $63M.
-
Who are XWPharma’s investors?
CDIB Capital Group, Orient Hontai Capital, Panacea Capital (California), Trinity Innovation Fund, and Woori Venture Partners are 5 of 9 investors who have invested in XWPharma.
-
Who are XWPharma’s competitors?
CervoMed, NeuroNascent, CuraSen, Aquinnah, and T3D Therapeutics are some of the 77 competitors of XWPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process